128 related articles for article (PubMed ID: 7511190)
1. Use of cell surface antigen phenotype in guiding therapeutic decisions in chronic myelomonocytic leukemia.
Woodlock TJ; Seshi B; Sham RL; Cyran EM; Bennett JM
Leuk Res; 1994 Mar; 18(3):173-81. PubMed ID: 7511190
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype.
Alsabeh R; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1997 Apr; 107(4):430-7. PubMed ID: 9124211
[TBL] [Abstract][Full Text] [Related]
3. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes.
Xie W; Wang X; Du W; Liu W; Qin X; Huang S
Cytometry A; 2010 Sep; 77(9):840-8. PubMed ID: 20662087
[TBL] [Abstract][Full Text] [Related]
4. Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome.
Grövdal M; Khan R; Aggerholm A; Antunovic P; Astermark J; Bernell P; Engström LM; Kjeldsen L; Linder O; Nilsson L; Olsson A; Wallvik J; Tangen JM; Oberg G; Jacobsen SE; Hokland P; Porwit A; Hellström-Lindberg E
Clin Cancer Res; 2007 Dec; 13(23):7107-12. PubMed ID: 18056190
[TBL] [Abstract][Full Text] [Related]
5. [Study on the immunophenotypes of bone marrow cells from patients with myelodysplastic syndromes and its clinical implications].
Wang JY; Li XM; Li FJ; Chen XG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Apr; 10(2):173-4. PubMed ID: 12513825
[TBL] [Abstract][Full Text] [Related]
6. CD4+, CD33-, CD13-, CD14- acute monoblastic leukaemia.
Lombard EH; Mansvelt EP
Acta Haematol; 1992; 87(3):151-2. PubMed ID: 1379402
[TBL] [Abstract][Full Text] [Related]
7. Differences in CD33 intensity between various myeloid neoplasms.
Jilani I; Estey E; Huh Y; Joe Y; Manshouri T; Yared M; Giles F; Kantarjian H; Cortes J; Thomas D; Keating M; Freireich E; Albitar M
Am J Clin Pathol; 2002 Oct; 118(4):560-6. PubMed ID: 12375643
[TBL] [Abstract][Full Text] [Related]
8. Dismal outcome of acute myeloid leukemia secondary to myelodysplastic syndrome and chronic myelomonocytic leukemia after azacitidine failure in a daily-life setting.
Niscola P; Tendas A; Cupelli L; Giovannini M; Piccioni D; Scaramucci L; Dentamaro T; Del Poeta G; de Fabritiis P
Acta Haematol; 2015; 133(1):64-6. PubMed ID: 25139255
[No Abstract] [Full Text] [Related]
9. Detection of minimal residual disease in a patient having acute myelogenous leukemia with t(16;21)(p11;q22) treated by allogeneic bone marrow transplantation.
Okoshi Y; Shimizu S; Kojima H; Obara N; Mukai HY; Komeno T; Hasegawa Y; Mori N; Nagasawa T
Acta Haematol; 2001; 105(1):45-8. PubMed ID: 11340253
[TBL] [Abstract][Full Text] [Related]
10. Surface marker expression in acute myeloid leukaemia at first relapse.
Thomas X; Campos L; Archimbaud E; Shi ZH; Treille-Ritouet D; Anglaret B; Fiere D
Br J Haematol; 1992 May; 81(1):40-4. PubMed ID: 1381608
[TBL] [Abstract][Full Text] [Related]
11. Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.
Vitale A; Guarini A; Ariola C; Meloni G; Perbellini O; Pizzuti M; De Gregoris C; Mettivier V; Pastorini A; Pizzolo G; Vignetti M; Mandelli F; Foà R
Haematologica; 2007 Mar; 92(3):342-8. PubMed ID: 17339183
[TBL] [Abstract][Full Text] [Related]
12. The proliferative activity of myelopoiesis in myelodysplasia evaluated by multiparameter flow cytometry.
Jensen IM; Hokland P
Br J Haematol; 1994 Jul; 87(3):477-82. PubMed ID: 7993787
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens.
Syrjälä M; Anttila VJ; Ruutu T; Jansson SE
Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295
[TBL] [Abstract][Full Text] [Related]
14. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure.
Maciejewski JP; Anderson S; Katevas P; Young NS
Br J Haematol; 1994 Jun; 87(2):227-34. PubMed ID: 7524621
[TBL] [Abstract][Full Text] [Related]
16. Acute lymphoblastic leukemia following preleukemic syndromes in adults.
Escudier SM; Albitar M; Robertson LE; Andreeff M; Pierce S; Kantarjian HM
Leukemia; 1996 Mar; 10(3):473-7. PubMed ID: 8642864
[TBL] [Abstract][Full Text] [Related]
17. [Leukemia cutis arising at the site of injection of a tetanus vaccine booster].
Guinovart RM; Carrascosa JM; Ferrándiz C
Actas Dermosifiliogr; 2010 Oct; 101(8):727-9. PubMed ID: 20965018
[No Abstract] [Full Text] [Related]
18. Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes.
Alhan C; Westers TM; van der Helm LH; Eeltink C; Huls G; Witte BI; Buchi F; Santini V; Ossenkoppele GJ; van de Loosdrecht AA
Cytometry B Clin Cytom; 2014 May; 86(3):207-15. PubMed ID: 24474614
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia.
Oliveira AF; Tansini A; Vidal DO; Lopes LF; Metze K; Lorand-Metze I
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27748021
[TBL] [Abstract][Full Text] [Related]
20. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG
J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
